TXNRD1 and neoplasm: Combinations of Cyst(e)inase with a TXNR inhibitor (Auranofin) or a PARP inhibitor (Olaparib) further increased DNA damage and led to synergistic reduction of cell survival in culture and synergistic reduction in PCa tumor growth in xenograft tumor models.